Paper - WANFANG MED ONLINE

You Position: Home > Paper

Dosimetric comparison between intensity modulated radiation therapy and three-dimensional conforreal radiotherapy in non-small cell lung cancer

( views:57, downloads:249 )

Author:: No author available

Journal Title:: CHINESE JOURNAL OF RADIATION ONCOLOGY

Issue:: 5

DOI:: 10.3760/cma.j.issn.1004-4221.2009.05.352

Key Word:: 肺肿瘤/放射疗法;放射疗法;三维适形;放射疗法;调强;剂量学;Lung neoplasms/radlotherapy;Radiotherapy;three-dimensional conformal;Radiotherapy;intensity modulated;Dosimetry

Abstract： SCLC can spare more volume of the normal lungs and e-sophagus, and has the ability of dose escalation.

Reference

[1]朱正飞,傅小龙.调强放疗在非小细胞肺癌中的应用[J].2007,(1).
[2]Wang S,Cox JD,Komaki R,etc.Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.[J].2007,68(1).
[3]J T, Lyman.Complication probability as assessed from dose-volume histograms.[J].1985,8.
[4]Liao Z,Wu Q,Komaki R,etc.Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.[J].2004,58(4).
[5]Joe Y, Chang,H Helen, Liu,Ritsuko, Komaki.Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer.[J].2005,7(4).
[6]D, Oetzel,P, Schraube,F, Hensley,etc.Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.[J].1995,33.
[7]S L, Kwa,J V, Lebesque,J C, Theuws,etc.Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.[J].1998,42.
[8]Kong FM,Hayman JA,Griffith KA,etc.Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.[J].2006,65(4).
[9]Perez CA,Lockett MA,Bosch W,etc.Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).[J].1999,45(2).
[10]Allen AM,Sugarbaker DJ,Baldini EH,etc.Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.[J].2006,65(3).
[11]Martel MK,Normolle DP,Turrisi AT,etc.Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.[J].2001,19(1).
[12]Rakesh R, Patel,Minesh, Mehta.Three-dimensional conformal radiotherapy for lung cancer: promises and pitfalls.[J].2002,4(4).
[13]T, Le Chevalier,R, Arriagada,E, Quoix,etc.Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.[J].1991,83.
[14]Belderbos JS,Seppenwoolde Y,Lebesque JV,etc.Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.[J].2004,60(3).
[15]Liao Z,Stevens C,Gopal R,etc.The relationship between local dose and loss of function for irradiated lung.[J].2003,56(1).
[16]Rodrigues G,Lock M,D'Souza D,etc.Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-a systematic review.[J].2004,71(2).
[17]Martel MK,Hayman JA,Ten Haken RK,etc.Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer.[J].2004,44(1).
[18]Huang H,Jirtle RL,Bentel G,etc.Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta.[J].2001,50(4).
[19]Murshed H,Liu HH,Liao Z,etc.Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.[J].2004,58(4).